| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6348210 | ALZA | Methods for transdermal drug administration |
Nov, 2019
(4 years ago) | |
Testoderm Tts is owned by Alza.
Testoderm Tts contains Testosterone.
Testoderm Tts has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Testoderm Tts are:
- US6348210
Testoderm Tts was authorised for market use on 18 December, 1997.
Testoderm Tts is available in film, extended release;transdermal dosage forms.
Testoderm Tts can be used as method for transdermal administration of a drug through non-scrotal skin using a transdermal drug delivery device containing the drug and having an adhesive surface.
The generics of Testoderm Tts are possible to be released after 10 November, 2019.
Drugs and Companies using TESTOSTERONE ingredient
Market Authorisation Date: 18 December, 1997
Treatment: Method for transdermal administration of a drug through non-scrotal skin using a transdermal drug delivery device containing the drug and having an adhesive surface
Dosage: FILM, EXTENDED RELEASE;TRANSDERMAL
TESTODERM TTS family patents
